193 related articles for article (PubMed ID: 23929008)
1. Silencing of S100A4, a metastasis-associated protein, in endothelial cells inhibits tumor angiogenesis and growth.
Ochiya T; Takenaga K; Endo H
Angiogenesis; 2014 Jan; 17(1):17-26. PubMed ID: 23929008
[TBL] [Abstract][Full Text] [Related]
2. Correlation of two distinct metastasis-associated proteins, MTA1 and S100A4, in angiogenesis for promoting tumor growth.
Ishikawa M; Osaki M; Yamagishi M; Onuma K; Ito H; Okada F; Endo H
Oncogene; 2019 Jun; 38(24):4715-4728. PubMed ID: 30745574
[TBL] [Abstract][Full Text] [Related]
3. Relaxin enhances S100A4 and promotes growth of human thyroid carcinoma cell xenografts.
Radestock Y; Willing C; Kehlen A; Hoang-Vu C; Hombach-Klonisch S
Mol Cancer Res; 2010 Apr; 8(4):494-506. PubMed ID: 20332215
[TBL] [Abstract][Full Text] [Related]
4. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF.
Jia W; Gao XJ; Zhang ZD; Yang ZX; Zhang G
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1495-508. PubMed ID: 23771538
[TBL] [Abstract][Full Text] [Related]
5. FOXA1 promotes prostate cancer angiogenesis by inducing multiple pro-angiogenic factors expression.
Su Y; Zhang Y; Zhao J; Zhou W; Wang W; Han B; Wang X
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3225-3243. PubMed ID: 34258652
[TBL] [Abstract][Full Text] [Related]
6. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.
Wang L; Wang X; Liang Y; Diao X; Chen Q
Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804
[TBL] [Abstract][Full Text] [Related]
7. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9.
Saleem M; Kweon MH; Johnson JJ; Adhami VM; Elcheva I; Khan N; Bin Hafeez B; Bhat KM; Sarfaraz S; Reagan-Shaw S; Spiegelman VS; Setaluri V; Mukhtar H
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14825-30. PubMed ID: 16990429
[TBL] [Abstract][Full Text] [Related]
8. Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin.
Chen M; Sinha M; Luxon BA; Bresnick AR; O'Connor KL
J Biol Chem; 2009 Jan; 284(3):1484-94. PubMed ID: 19011242
[TBL] [Abstract][Full Text] [Related]
9. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis.
Mu HQ; He YH; Wang SB; Yang S; Wang YJ; Nan CJ; Bao YF; Xie QP; Chen YH
Clin Transl Oncol; 2020 Jan; 22(1):111-121. PubMed ID: 31667686
[TBL] [Abstract][Full Text] [Related]
10. S100A4 and its role in metastasis – simulations of knockout and amplification of epithelial growth factor receptor and matrix metalloproteinases.
Buetti-Dinh A; Pivkin IV; Friedman R
Mol Biosyst; 2015 Aug; 11(8):2247-54. PubMed ID: 26057862
[TBL] [Abstract][Full Text] [Related]
11. Lectin-like oxidized LDL receptor-1 is an enhancer of tumor angiogenesis in human prostate cancer cells.
González-Chavarría I; Cerro RP; Parra NP; Sandoval FA; Zuñiga FA; Omazábal VA; Lamperti LI; Jiménez SP; Fernandez EA; Gutiérrez NA; Rodriguez FS; Onate SA; Sánchez O; Vera JC; Toledo JR
PLoS One; 2014; 9(8):e106219. PubMed ID: 25170920
[TBL] [Abstract][Full Text] [Related]
12. EphA6 promotes angiogenesis and prostate cancer metastasis and is associated with human prostate cancer progression.
Li S; Ma Y; Xie C; Wu Z; Kang Z; Fang Z; Su B; Guan M
Oncotarget; 2015 Sep; 6(26):22587-97. PubMed ID: 26041887
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic targeting of tumor growth and angiogenesis with a novel anti-S100A4 monoclonal antibody.
Hernández JL; Padilla L; Dakhel S; Coll T; Hervas R; Adan J; Masa M; Mitjans F; Martinez JM; Coma S; Rodríguez L; Noé V; Ciudad CJ; Blasco F; Messeguer R
PLoS One; 2013; 8(9):e72480. PubMed ID: 24023743
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of S100A4 blocks growth and metastasis of anaplastic thyroid cancer cells in vitro and in vivo.
Zhang K; Yu M; Hao F; Dong A; Chen D
Cancer Biomark; 2016 Sep; 17(3):281-291. PubMed ID: 27802204
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of metastasis-associated protein S100A4 (Mts1) in prostate cancer progression and chemoprevention regimens in an autochthonous mouse model.
Saleem M; Adhami VM; Ahmad N; Gupta S; Mukhtar H
Clin Cancer Res; 2005 Jan; 11(1):147-53. PubMed ID: 15671539
[TBL] [Abstract][Full Text] [Related]
16. RNA interference targeting inhibition of S100A4 suppresses cell growth and promotes apoptosis in human laryngeal carcinoma Hep‑2 cells.
Liu J; Fu S; Xu Y; Zheng Z
Mol Med Rep; 2014 Sep; 10(3):1389-94. PubMed ID: 24969174
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.
Kong D; Li Y; Wang Z; Banerjee S; Sarkar FH
Cancer Res; 2007 Apr; 67(7):3310-9. PubMed ID: 17409440
[TBL] [Abstract][Full Text] [Related]
18. Blocking TGF-β inhibits breast cancer cell invasiveness via ERK/S100A4 signal.
Wang XG; Meng Q; Qi FM; Yang QF
Eur Rev Med Pharmacol Sci; 2014; 18(24):3844-53. PubMed ID: 25555875
[TBL] [Abstract][Full Text] [Related]
19. Silencing of CCR7 inhibits the growth, invasion and migration of prostate cancer cells induced by VEGFC.
Chi BJ; Du CL; Fu YF; Zhang YN; Wang RW
Int J Clin Exp Pathol; 2015; 8(10):12533-40. PubMed ID: 26722441
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
Zhang G; Li M; Jin J; Bai Y; Yang C
Asian Pac J Cancer Prev; 2011; 12(8):2075-80. PubMed ID: 22292654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
